Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 201

1.

A Gorilla Adenovirus-Based Vaccine against Zika Virus Induces Durable Immunity and Confers Protection in Pregnancy.

Hassan AO, Dmitriev IP, Kashentseva EA, Zhao H, Brough DE, Fremont DH, Curiel DT, Diamond MS.

Cell Rep. 2019 Sep 3;28(10):2634-2646.e4. doi: 10.1016/j.celrep.2019.08.005.

2.

Application of PEG-Covered Non-Biodegradable Polyelectrolyte Microcapsules in the Crustacean Circulatory System on the Example of the Amphipod Eulimnogammarus verrucosus.

Shchapova E, Nazarova A, Gurkov A, Borvinskaya E, Rzhechitskiy Y, Dmitriev I, Meglinski I, Timofeyev M.

Polymers (Basel). 2019 Jul 27;11(8). pii: E1246. doi: 10.3390/polym11081246.

3.

Pancreas transplantation with isolated splenic artery blood supply - Single center experience.

Pinchuk AV, Dmitriev IV, Anisimov YA, Storozhev RV, Balkarov AG, Kondrashkin AS, Khodilina IV, Muslimov RS.

Asian J Surg. 2019 Jul 10. pii: S1015-9584(19)30224-6. doi: 10.1016/j.asjsur.2019.06.011. [Epub ahead of print]

4.

[Pancreas transplantation with isolated blood supply through the splenic artery].

Pinchuk AV, Anisimov IA, Dmitriev IV, Storozhev RV, Balkarov AG, Muslimov RS, Khodilina IV.

Angiol Sosud Khir. 2019;25(1):125-129. doi: 10.33529/angio2019117. Russian.

PMID:
30994618
5.

[Pancreas transplantation followed by stumpless duodenal exocrine drainage].

Pinchuk AV, Dmitriev IV, Storozhev RV, Balkarov AG, Anisimov YA, Kondrashkin AS.

Khirurgiia (Mosk). 2019;(2):89-95. doi: 10.17116/hirurgia201902189. Russian.

PMID:
30855597
6.

Endoscopic treatment of perforated duodenal ulcer using a partially polyurethane-covered self-expandable nitinol stent: A case report.

Yartsev P, Kirsanov I, Teterin Y, Dmitriev I, Lebedev A, Kazakova V.

Asian J Endosc Surg. 2019 Mar 6. doi: 10.1111/ases.12697. [Epub ahead of print]

PMID:
30843334
7.

Defining a murine ovarian cancer model for the evaluation of conditionally-replicative adenovirus (CRAd) virotherapy agents.

González-Pastor R, Ashshi AM, El-Shemi AG, Dmitriev IP, Kashentseva EA, Lu ZH, Goedegebuure SP, Podhajcer OL, Curiel DT.

J Ovarian Res. 2019 Feb 15;12(1):18. doi: 10.1186/s13048-019-0493-5.

8.

[Treatment of postoperative ventral hernias in recipients of solitary organs].

Kondrashkin AS, Khodilina IV, Yartsev PA, Dmitriev IV, Novruzbekov MS, Pinchuk AV.

Khirurgiia (Mosk). 2018;(12):65-72. doi: 10.17116/hirurgia201812165. Russian.

PMID:
30560847
9.

Improved Induction of Anti-Melanoma T Cells by Adenovirus-5/3 Fiber Modification to Target Human DCs.

Chondronasiou D, Eisden TTHD, Stam AGM, Matthews QL, Icyuz M, Hooijberg E, Dmitriev I, Curiel DT, de Gruijl TD, van de Ven R.

Vaccines (Basel). 2018 Jul 18;6(3). pii: E42. doi: 10.3390/vaccines6030042.

10.

Inclusion of the murine IgGκ signal peptide increases the cellular immunogenicity of a simian adenoviral vectored Plasmodium vivax multistage vaccine.

Fonseca JA, McCaffery JN, Caceres J, Kashentseva E, Singh B, Dmitriev IP, Curiel DT, Moreno A.

Vaccine. 2018 May 11;36(20):2799-2808. doi: 10.1016/j.vaccine.2018.03.091. Epub 2018 Apr 12.

11.

Adenovirus platform enhances transduction efficiency of human mesenchymal stem cells: An opportunity for cellular carriers of targeted TRAIL-based TR3 biologics in ovarian cancer.

Kuroki LM, Jin X, Dmitriev IP, Kashentseva EA, Powell MA, Mutch DG, Dietz AB, Curiel DT, Hawkins WG, Spitzer D.

PLoS One. 2017 Dec 21;12(12):e0190125. doi: 10.1371/journal.pone.0190125. eCollection 2017.

12.

Development of an adenovirus vector vaccine platform for targeting dendritic cells.

Sharma PK, Dmitriev IP, Kashentseva EA, Raes G, Li L, Kim SW, Lu ZH, Arbeit JM, Fleming TP, Kaliberov SA, Goedegebuure SP, Curiel DT, Gillanders WE.

Cancer Gene Ther. 2018 Feb;25(1-2):27-38. doi: 10.1038/s41417-017-0002-1. Epub 2017 Dec 15.

13.

Retroperitoneal Pancreas Transplantation With the Use of Duodenal Drainage via "Button Technique": First Clinical Practice (Case Report).

Pinchuk A, Dmitriev I, Lazareva K, Storozhev R, Balkarov A, Anisimov Y, Kondrashkin A.

Transplant Proc. 2017 Dec;49(10):2347-2351. doi: 10.1016/j.transproceed.2017.10.005.

PMID:
29198675
14.

A framework for continuous target tracking during MR-guided high intensity focused ultrasound thermal ablations in the abdomen.

Zachiu C, Denis de Senneville B, Dmitriev ID, Moonen CTW, Ries M.

J Ther Ultrasound. 2017 Oct 9;5:27. doi: 10.1186/s40349-017-0106-y. eCollection 2017.

15.

A prime-boost immunization regimen based on a simian adenovirus 36 vectored multi-stage malaria vaccine induces protective immunity in mice.

Fonseca JA, McCaffery JN, Kashentseva E, Singh B, Dmitriev IP, Curiel DT, Moreno A.

Vaccine. 2017 May 31;35(24):3239-3248. doi: 10.1016/j.vaccine.2017.04.062. Epub 2017 May 5.

16.

Endoscopic findings following retroperitoneal pancreas transplantation.

Pinchuk AV, Dmitriev IV, Shmarina NV, Teterin YS, Balkarov AG, Storozhev RV, Anisimov YA, Gasanov AM.

Clin Transplant. 2017 Jul;31(7). doi: 10.1111/ctr.12989. Epub 2017 May 22.

PMID:
28444815
17.

A Recombinant Chimeric Ad5/3 Vector Expressing a Multistage Plasmodium Antigen Induces Protective Immunity in Mice Using Heterologous Prime-Boost Immunization Regimens.

Cabrera-Mora M, Fonseca JA, Singh B, Zhao C, Makarova N, Dmitriev I, Curiel DT, Blackwell J, Moreno A.

J Immunol. 2016 Oct 1;197(7):2748-61. doi: 10.4049/jimmunol.1501926. Epub 2016 Aug 29.

18.

A One Health overview, facilitating advances in comparative medicine and translational research.

Stroud C, Dmitriev I, Kashentseva E, Bryan JN, Curiel DT, Rindt H, Reinero C, Henry CJ, Bergman PJ, Mason NJ, Gnanandarajah JS, Engiles JB, Gray F, Laughlin D, Gaurnier-Hausser A, Wallecha A, Huebner M, Paterson Y, O'Connor D, Treml LS, Stannard JP, Cook JL, Jacobs M, Wyckoff GJ, Likins L, Sabbagh U, Skaff A, Guloy AS, Hays HD, LeBlanc AK, Coates JR, Katz ML, Lyons LA, Johnson GC, Johnson GS, O'Brien DP, Duan D, Calvet JP, Gandolfi B, Baron DA, Weiss ML, Webster DA, Karanu FN, Robb EJ, Harman RJ.

Clin Transl Med. 2016 Aug;5(Suppl 1):26. doi: 10.1186/s40169-016-0107-4.

19.

Anomalous Hall Effect in a 2D Rashba Ferromagnet.

Ado IA, Dmitriev IA, Ostrovsky PM, Titov M.

Phys Rev Lett. 2016 Jul 22;117(4):046601. doi: 10.1103/PhysRevLett.117.046601. Epub 2016 Jul 20.

PMID:
27494487
20.

A Tetraspecific VHH-Based Neutralizing Antibody Modifies Disease Outcome in Three Animal Models of Clostridium difficile Infection.

Schmidt DJ, Beamer G, Tremblay JM, Steele JA, Kim HB, Wang Y, Debatis M, Sun X, Kashentseva EA, Dmitriev IP, Curiel DT, Shoemaker CB, Tzipori S.

Clin Vaccine Immunol. 2016 Sep 6;23(9):774-84. doi: 10.1128/CVI.00730-15. Print 2016 Sep.

21.

Combinatorial strategies based on CRAd-IL24 and CRAd-ING4 virotherapy with anti-angiogenesis treatment for ovarian cancer.

Ashshi AM, El-Shemi AG, Dmitriev IP, Kashentseva EA, Curiel DT.

J Ovarian Res. 2016 Jun 27;9(1):38. doi: 10.1186/s13048-016-0248-5.

22.

[Morphological diagnostics of fat embolism].

Dorosevich AE, Dmitriev IV.

Sud Med Ekspert. 2016 Jan-Feb;59(1):43-47. doi: 10.17116/sudmed201659143-47. Review. Russian.

PMID:
27144263
23.

Erratum: Membrane-proximal TRAIL species are incapable of inducing short circuit apoptosis signaling: Implications for drug development and basic cytokine biology.

Tatzel K, Kuroki L, Dmitriev I, Kashentseva E, Curiel DT, Goedegebuure SP, Powell MA, Mutch DG, Hawkins WG, Spitzer D.

Sci Rep. 2016 May 4;6:25217. doi: 10.1038/srep25217. No abstract available.

24.

A Plasmodium Promiscuous T Cell Epitope Delivered within the Ad5 Hexon Protein Enhances the Protective Efficacy of a Protein Based Malaria Vaccine.

Fonseca JA, Cabrera-Mora M, Kashentseva EA, Villegas JP, Fernandez A, Van Pelt A, Dmitriev IP, Curiel DT, Moreno A.

PLoS One. 2016 Apr 29;11(4):e0154819. doi: 10.1371/journal.pone.0154819. eCollection 2016.

25.

Membrane-proximal TRAIL species are incapable of inducing short circuit apoptosis signaling: Implications for drug development and basic cytokine biology.

Tatzel K, Kuroki L, Dmitriev I, Kashentseva E, Curiel DT, Goedegebuure SP, Powell MA, Mutch DG, Hawkins WG, Spitzer D.

Sci Rep. 2016 Mar 3;6:22661. doi: 10.1038/srep22661. Erratum in: Sci Rep. 2016 May 04;6:25217.

26.

Surgical complications after simultaneous pancreas-kidney transplantation: A single-center experience.

Khubutia MS, Pinchuk AV, Dmitriev IV, Balkarov AG, Storozhev RV, Anisimov YA.

Asian J Surg. 2016 Oct;39(4):232-7. doi: 10.1016/j.asjsur.2015.11.003. Epub 2016 Feb 5.

27.

Adenoviral Expression of a Bispecific VHH-Based Neutralizing Agent That Targets Protective Antigen Provides Prophylactic Protection from Anthrax in Mice.

Moayeri M, Tremblay JM, Debatis M, Dmitriev IP, Kashentseva EA, Yeh AJ, Cheung GY, Curiel DT, Leppla S, Shoemaker CB.

Clin Vaccine Immunol. 2016 Jan 6;23(3):213-8. doi: 10.1128/CVI.00611-15.

28.

Spin-Selective Electron Quantum Transport in Nonmagnetic MgZnO/ZnO Heterostructures.

Maryenko D, Falson J, Bahramy MS, Dmitriev IA, Kozuka Y, Tsukazaki A, Kawasaki M.

Phys Rev Lett. 2015 Nov 6;115(19):197601. doi: 10.1103/PhysRevLett.115.197601. Epub 2015 Nov 5.

PMID:
26588414
29.

Association between Parenchymal Enhancement of the Contralateral Breast in Dynamic Contrast-enhanced MR Imaging and Outcome of Patients with Unilateral Invasive Breast Cancer.

van der Velden BH, Dmitriev I, Loo CE, Pijnappel RM, Gilhuijs KG.

Radiology. 2015 Sep;276(3):675-85. doi: 10.1148/radiol.15142192. Epub 2015 Mar 26.

PMID:
25811614
30.

The N-Terminal Domain of SIRT1 Is a Positive Regulator of Endogenous SIRT1-Dependent Deacetylation and Transcriptional Outputs.

Ghisays F, Brace CS, Yackly SM, Kwon HJ, Mills KF, Kashentseva E, Dmitriev IP, Curiel DT, Imai SI, Ellenberger T.

Cell Rep. 2015 Mar 17;10(10):1665-1673. doi: 10.1016/j.celrep.2015.02.036. Epub 2015 Mar 12.

31.

Adenovirus vector expressing Stx1/Stx2-neutralizing agent protects piglets infected with Escherichia coli O157:H7 against fatal systemic intoxication.

Sheoran AS, Dmitriev IP, Kashentseva EA, Cohen O, Mukherjee J, Debatis M, Shearer J, Tremblay JM, Beamer G, Curiel DT, Shoemaker CB, Tzipori S.

Infect Immun. 2015 Jan;83(1):286-91. doi: 10.1128/IAI.02360-14. Epub 2014 Nov 3.

32.

Monitoring of biodistribution and persistence of conditionally replicative adenovirus in a murine model of ovarian cancer using capsid-incorporated mCherry and expression of human somatostatin receptor subtype 2 gene.

Dmitriev IP, Kashentseva EA, Kim KH, Matthews QL, Krieger SS, Parry JJ, Nguyen KN, Akers WJ, Achilefu S, Rogers BE, Alvarez RD, Curiel DT.

Mol Imaging. 2014;13. doi: 10.2310/7290.2014.00024.

PMID:
25249483
33.

Prolonged prophylactic protection from botulism with a single adenovirus treatment promoting serum expression of a VHH-based antitoxin protein.

Mukherjee J, Dmitriev I, Debatis M, Tremblay JM, Beamer G, Kashentseva EA, Curiel DT, Shoemaker CB.

PLoS One. 2014 Aug 29;9(8):e106422. doi: 10.1371/journal.pone.0106422. eCollection 2014.

34.

Simultaneous pancreas-kidney transplantation with duodeno-duodenal anastomosis.

Khubutia M, Pinchuk A, Dmitriev I, Storozhev R.

Transplant Proc. 2014 Jul-Aug;46(6):1905-9. doi: 10.1016/j.transproceed.2014.05.070.

PMID:
25131067
35.

Emergence of domains and nonlinear transport in the zero-resistance state.

Dmitriev IA, Khodas M, Mirlin AD, Polyakov DG.

Phys Rev Lett. 2013 Nov 15;111(20):206801. Epub 2013 Nov 11.

PMID:
24289699
36.

Enhanced prostate cancer gene transfer and therapy using a novel serotype chimera cancer terminator virus (Ad.5/3-CTV).

Azab BM, Dash R, Das SK, Bhutia SK, Sarkar S, Shen XN, Quinn BA, Dent P, Dmitriev IP, Wang XY, Curiel DT, Pellecchia M, Reed JC, Sarkar D, Fisher PB.

J Cell Physiol. 2014 Jan;229(1):34-43. doi: 10.1002/jcp.24408.

37.

A phase I clinical trial of Ad5/3-Δ24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer.

Kim KH, Dmitriev IP, Saddekni S, Kashentseva EA, Harris RD, Aurigemma R, Bae S, Singh KP, Siegal GP, Curiel DT, Alvarez RD.

Gynecol Oncol. 2013 Sep;130(3):518-24. doi: 10.1016/j.ygyno.2013.06.003. Epub 2013 Jun 10.

38.

Fully automated deformable registration of breast DCE-MRI and PET/CT.

Dmitriev ID, Loo CE, Vogel WV, Pengel KE, Gilhuijs KG.

Phys Med Biol. 2013 Feb 21;58(4):1221-33. doi: 10.1088/0031-9155/58/4/1221. Epub 2013 Feb 1.

PMID:
23369926
39.

Insulin-like growth factor-binding protein-7 (IGFBP7): a promising gene therapeutic for hepatocellular carcinoma (HCC).

Chen D, Siddiq A, Emdad L, Rajasekaran D, Gredler R, Shen XN, Santhekadur PK, Srivastava J, Robertson CL, Dmitriev I, Kashentseva EA, Curiel DT, Fisher PB, Sarkar D.

Mol Ther. 2013 Apr;21(4):758-66. doi: 10.1038/mt.2012.282. Epub 2013 Jan 15. Erratum in: Mol Ther. 2015 Jul;23(7):1278.

40.

CryoEM visualization of an adenovirus capsid-incorporated HIV antigen.

Flatt JW, Fox TL, Makarova N, Blackwell JL, Dmitriev IP, Kashentseva EA, Curiel DT, Stewart PL.

PLoS One. 2012;7(11):e49607. doi: 10.1371/journal.pone.0049607. Epub 2012 Nov 14.

41.

[Treatment of mild exacerbations of chronic obstructive pulmonary disease].

Kliachkina IL, Dmitriev IuK.

Klin Med (Mosk). 2012;90(3):69-73. Russian.

PMID:
22690572
42.

A phase I clinical trial of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in patients with recurrent gynecologic cancer.

Kim KH, Dmitriev I, O'Malley JP, Wang M, Saddekni S, You Z, Preuss MA, Harris RD, Aurigemma R, Siegal GP, Zinn KR, Curiel DT, Alvarez RD.

Clin Cancer Res. 2012 Jun 15;18(12):3440-51. doi: 10.1158/1078-0432.CCR-11-2852. Epub 2012 Apr 17.

43.

[Modeling of protein spatial structure using tritium planigraphy].

Bogacheva EN, Bogachev AN, Dmitriev IB, Dolgov AA, Chulichkov AL, Shishkov AV, Baratova LA.

Biofizika. 2011 Nov-Dec;56(6):1024-37. Russian.

PMID:
22279745
44.

Targeting Mcl-1 for the therapy of cancer.

Quinn BA, Dash R, Azab B, Sarkar S, Das SK, Kumar S, Oyesanya RA, Dasgupta S, Dent P, Grant S, Rahmani M, Curiel DT, Dmitriev I, Hedvat M, Wei J, Wu B, Stebbins JL, Reed JC, Pellecchia M, Sarkar D, Fisher PB.

Expert Opin Investig Drugs. 2011 Oct;20(10):1397-411. doi: 10.1517/13543784.2011.609167. Epub 2011 Aug 19. Review.

45.

Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) in combination with the Apogossypol derivative BI-97C1 (Sabutoclax) improves therapeutic efficacy in low CAR colorectal cancer cells.

Azab B, Dash R, Das SK, Bhutia SK, Shen XN, Quinn BA, Sarkar S, Wang XY, Hedvat M, Dmitriev IP, Curiel DT, Grant S, Dent P, Reed JC, Pellecchia M, Sarkar D, Fisher PB.

J Cell Physiol. 2012 May;227(5):2145-53. doi: 10.1002/jcp.22947.

46.

Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24-mediated toxicity.

Dash R, Azab B, Quinn BA, Shen X, Wang XY, Das SK, Rahmani M, Wei J, Hedvat M, Dent P, Dmitriev IP, Curiel DT, Grant S, Wu B, Stebbins JL, Pellecchia M, Reed JC, Sarkar D, Fisher PB.

Proc Natl Acad Sci U S A. 2011 May 24;108(21):8785-90. doi: 10.1073/pnas.1100769108. Epub 2011 May 9. Erratum in: Proc Natl Acad Sci U S A. 2017 May 30;114(22):E4522-E4523.

47.

Developing an effective gene therapy for prostate cancer: New technologies with potential to translate from the laboratory into the clinic.

Dash R, Azab B, Shen XN, Sokhi UK, Sarkar S, Su ZZ, Wang XY, Claudio PP, Dent P, Dmitriev IP, Curiel DT, Grant S, Sarkar D, Fisher PB.

Discov Med. 2011 Jan;11(56):46-56. Review.

48.

A serotype 5/3 adenovirus expressing MDA-7/IL-24 infects renal carcinoma cells and promotes toxicity of agents that increase ROS and ceramide levels.

Park MA, Hamed HA, Mitchell C, Cruickshanks N, Dash R, Allegood J, Dmitriev IP, Tye G, Ogretmen B, Spiegel S, Yacoub A, Grant S, Curiel DT, Fisher PB, Dent P.

Mol Pharmacol. 2011 Mar;79(3):368-80. doi: 10.1124/mol.110.069484. Epub 2010 Nov 30.

49.

Enhancing mda-7/IL-24 therapy in renal carcinoma cells by inhibiting multiple protective signaling pathways using sorafenib and by Ad.5/3 gene delivery.

Eulitt PJ, Park MA, Hossein H, Cruikshanks N, Yang C, Dmitriev IP, Yacoub A, Curiel DT, Fisher PB, Dent P.

Cancer Biol Ther. 2010 Dec 15;10(12):1290-305. Epub 2010 Dec 15.

50.

mda-7/IL-24: a unique member of the IL-10 gene family promoting cancer-targeted toxicity.

Dash R, Bhutia SK, Azab B, Su ZZ, Quinn BA, Kegelmen TP, Das SK, Kim K, Lee SG, Park MA, Yacoub A, Rahmani M, Emdad L, Dmitriev IP, Wang XY, Sarkar D, Grant S, Dent P, Curiel DT, Fisher PB.

Cytokine Growth Factor Rev. 2010 Oct;21(5):381-91. doi: 10.1016/j.cytogfr.2010.08.004. Review.

Supplemental Content

Loading ...
Support Center